Myeloablative Allo Stem Cell Transplant
Myeloablative Allogeneic Hematopoietic Stem Cell Transplant With Related or Unrelated Donor for Hematological Disorders
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 300 patients (estimated)
- Sponsors
- University of Minnesota - Masonic Cancer Center
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, Radiation Therapy
- Trial Type
- Treatment
- Last Update
- 2 months ago
- SparkCures ID
- 1197
- NCT Identifier
- NCT03314974
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.